MedPath

Comparison of naloxone & buprenorphine on reversal of Opioid Overdose Syndrome and withdrawal in Methadone – Dependant Patients; An experimental Study

Early Phase 1
Completed
Conditions
Poisoning by Methadone
Methadone Overdose.
Registration Number
IRCT2015011020624N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

all opioid-dependant patients who refer after methadone overdose will be included and randomly assigned into either case (buprenorphine with two different doses) or control (naloxone) group.
Exclusion criteria:
1-Those younger than 12 years of age and older than 100 years will be excluded.
2- Patients with multiple drug overdoses will be excluded.
3-Patients who do not respond to the buprenorphien and naloxone doses and are in life-treathening situation will be intubated and excluded from the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reversal of Respiratory Depression. Timepoint: 1 min. Method of measurement: reversal of respiratory rate.
Secondary Outcome Measures
NameTimeMethod
Reversal of cyanosis and increased O2 Saturation. Timepoint: 2 minutes. Method of measurement: Pulse Oximetry.
© Copyright 2025. All Rights Reserved by MedPath